cytosine arabinoside ( ara-c ) treatment of peripheral blood mononuclear cells from 12/12 chronic-phase chronic myelogenous leukaemia ( cml ) patients revealed a proliferative response stimulated by their untreated leukaemic cells .
C0023474
chronic-phase chronic myelogenous leukaemia
C1517806
leukaemic cells